Literature DB >> 1011018

Lactate dehydrogenase and aspartete transaminase of the cerebrospinal fluid in patients with brain tumours, congenital hydrocephalus, and brain abscess.

S R Dharker, R S Dharker, B D Chaurasia.   

Abstract

The diagnostic value of CSF lactate dehydrogenase and aspartate transaminase in cases of brain tumours (except for CSF AST in the benign tumours), congenital hydrocephalus, and brain abscess is established. Tumour cyst fluids show a higher enzymatic activity than does the CSF. The two enzyme estimations do not help in differentiating the supratentorial from the infratentorial tumours. CSF AST is superior to CSF LD in discriminating the malignant and benign tumours, in so far as the AST is increases selectively in malignancy. Estimates of CSF LD are slightly superior to those of CSF AST, both in incidence of abnormality and the degree of their rise.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1011018      PMCID: PMC1083307          DOI: 10.1136/jnnp.39.11.1081

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  THE CEREBROSPINAL-FLUID GLUTAMIC OXALOACETIC TRANSAMINASE ACTIVITY IN NEUROLOGICAL DISEASES.

Authors:  R S MELLICK; R L BASSETT
Journal:  Lancet       Date:  1964-04-25       Impact factor: 79.321

2.  The diagnostic value of the chemical examination of cerebral cyst fluids.

Authors:  H B SZLIWOWSKI; J N CUMINGS
Journal:  Brain       Date:  1961-06       Impact factor: 13.501

3.  Cerebrospinal fluid-glutamic oxalacetic acid transaminase in patients receiving electroconvulsive therapy and in neurologic diseases.

Authors:  S H MANN; N DEPASQUALE; R PATERSON
Journal:  Neurology       Date:  1960-04       Impact factor: 9.910

4.  A study of human serum transaminases.

Authors:  J KING
Journal:  J Med Lab Technol       Date:  1960-01

5.  Activity of lactic dehydrogenase in spinal fluid.

Authors:  F WROBLEWSKI; B DECKER; R WROBLEWSKI
Journal:  Am J Clin Pathol       Date:  1957-09       Impact factor: 2.493

6.  Glutamic-oxalacetic transaminase activity in spinal fluid.

Authors:  R KATZMAN; R A FISHMAN; E S GOLDENSOHN
Journal:  Neurology       Date:  1957-12       Impact factor: 9.910

7.  The clinical implications of spinal-fluid lactic dehydrogenase activity.

Authors:  F WROBLEWSKI; B DECKER; R WROBLEWSKI
Journal:  N Engl J Med       Date:  1958-03-27       Impact factor: 91.245

8.  Lactic dehydrogenase of cerebrospinal fluid in the differential diagnosis of cerebrovascular disease and brain tumor.

Authors:  R K JAKOBY; W B JAKOBY
Journal:  J Neurosurg       Date:  1958-01       Impact factor: 5.115

9.  Cerebrospinal fluid transaminase and lactic dehydrogenase activities in neurologic disease.

Authors:  J B GREEN; H A OLDEWURTEL; D S O'DOHERTY; F M FORSTER
Journal:  AMA Arch Neurol Psychiatry       Date:  1958-08

10.  ENZYME STUDIES IN CEREBRAL TUMOURS. LACTATE DEHYDROGENASE, GLUCOSE PHOSPHATE ISOMERASE, ACID AND ALKALINE PHOSPHATASE IN PLASMA, VENTRICULAR CEREBROSPINAL FLUID AND TUMOUR CYST FLUID FROM CASES OF GLIOMA AND CEREBRAL SECONDARY CARCINOMA.

Authors:  M BUCKELL; M C ROBERTSON
Journal:  Br J Cancer       Date:  1965-03       Impact factor: 7.640

View more
  2 in total

1.  Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours.

Authors:  A Twijnstra; A P van Zanten; A A Hart; B W Ongerboer de Visser
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-03       Impact factor: 10.154

2.  Predictive value of serum lactate dehydrogenase in head injury.

Authors:  C J Rao; P K Shukla; S Mohanty; Y J Reddy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-10       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.